Home/Filings/4/0001209191-23-015041
4//SEC Filing

Glezer Stanislav 4

Accession 0001209191-23-015041

CIK 0001294133other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 8:37 PM ET

Size

17.5 KB

Accession

0001209191-23-015041

Insider Transaction Report

Form 4
Period: 2023-02-28
Glezer Stanislav
EVP, Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-03-01+2,2725,995 total
  • Tax Payment

    Common Stock

    2023-03-01$15.56/sh1,142$17,7704,853 total
  • Exercise/Conversion

    Common Stock

    2023-03-01+4,5569,409 total
  • Exercise/Conversion

    Restricted Stock Unit

    2023-03-013,7877,573 total
    Common Stock (3,787 underlying)
  • Award

    Restricted Stock Unit

    2023-02-28+28,07928,079 total
    Common Stock (28,079 underlying)
  • Tax Payment

    Common Stock

    2023-03-01$15.56/sh2,568$39,9586,841 total
  • Exercise/Conversion

    Restricted Stock Unit

    2023-03-017697,686 total
    Common Stock (769 underlying)
Footnotes (7)
  • [F1]The reported securities represent shares earned and vested on March 1, 2023 based on achievement of the financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on March 1, 2022.
  • [F2]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2022 performance-based restricted award granted on March 1, 2022 and vested on March 1, 2023.
  • [F3]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2023.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
  • [F5]Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.
  • [F6]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.
  • [F7]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2024, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.

Issuer

Inogen Inc

CIK 0001294133

Entity typeother

Related Parties

1
  • filerCIK 0001866861

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 8:37 PM ET
Size
17.5 KB